Development Level

Tbio 2 | 10,625
Tclin 2 | 602

IMPC Term

abnormal behavioral response t... 1 | 52

Disease

psoriasis 3 | 6,685
Alzheimer's disease 2 | 644
Cocaine-Related Disorders 2 | 88
Pain agnosia 2 | 99
lung cancer 2 | 4,466
medulloblastoma 2 | 1,524
ovarian cancer 2 | 8,484
subependymal giant cell astrocytoma 2 | 2,287
Adenocarcinoma 1 | 115
Agitation associated with Bipolar Mania 1 | 5
Agitation associated with Schizophrenia 1 | 5
Alcohol dependence 1 | 107
Amnestic disorder 1 | 37
Animal Mammary Neoplasms 1 | 136
Anxiety disorder 1 | 22
Apnea 1 | 3
Atrial Fibrillation 1 | 110
Atrophic vaginitis 1 | 14
Bipolar Disorder 1 | 266
Bipolar affective disorder, current episode manic 1 | 13
Bipolar disorder in remission 1 | 19
Bladder Neoplasm 1 | 109
Bradycardia 1 | 24
Bruxism 1 | 19
Cancer 1 | 2,346
Carcinoma, Transitional Cell 1 | 31
Cardiac Arrhythmia 1 | 20
Colorectal Neoplasms 1 | 217
Coronary artery disease 1 | 240
Coronary heart disease 1 | 59
Depression Treatment Adjunct 1 | 5
Drug psychosis 1 | 6
Dyspareunia 1 | 3
Endometrial Neoplasms 1 | 50
Endometriosis 1 | 535
Epilepsy 1 | 346
Female hypogonadism syndrome 1 | 7
Female infertility 1 | 28
Fever 1 | 34
Generalized anxiety disorder 1 | 29
Gout 1 | 93
Hypoactive sexual desire disorder 1 | 9
IGA Glomerulonephritis 1 | 454
Idiopathic scoliosis 1 | 29
Infantile autism 1 | 4
Infertility 1 | 163
Learning Disorders 1 | 27
Lithiasis 1 | 1
Lupus erythematosus 1 | 80
Major Depressive Disorder 1 | 106
Male infertility 1 | 170
Mammary Neoplasms 1 | 410
Mammary Neoplasms, Experimental 1 | 150
Memory Disorders 1 | 36
Menopausal flushing 1 | 17
Metastatic Breast Cancer Progression Post-Antiestrogen Therapy 1 | 4
Migraine 1 | 79
Mixed bipolar I disorder 1 | 9
Motion sickness 1 | 32
Movement disease 1 | 10
Neuroleptic malignant syndrome 1 | 8
Osteoporosis 1 | 257
Ovarian dysfunction 1 | 19
Pain 1 | 70
Parkinson's disease 1 | 364
Personality disorder 1 | 25
Pick disease 1 | 1,893
Postmenopausal osteoporosis 1 | 19
Premature ejaculation 1 | 16
Prevention of Breast Carcinoma 1 | 5
Prostatic Intraepithelial Neoplasias 1 | 11
Prostatic Neoplasms 1 | 471
Psychoses, Substance-Induced 1 | 17
Schizoaffective disorder 1 | 33
Schizophrenia 1 | 501
Seizures 1 | 95
Sexual dysfunction 1 | 10
Stomach Neoplasms 1 | 282
Substance abuse 1 | 55
Sudden infant death syndrome 1 | 33
Transsexualism 1 | 4
Tremor 1 | 8
Tularemia 1 | 22
Vascular disease 1 | 281
astrocytic glioma 1 | 2,241
astrocytoma 1 | 1,493
chronic lymphosyte leukemia 1 | 232
cystic fibrosis 1 | 1,665
ependymoma 1 | 2,514
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
lung adenocarcinoma 1 | 2,713
mucosa-associated lymphoid tissue lymphoma 1 | 480
non-small cell lung cancer 1 | 2,798
oligodendroglioma 1 | 2,849
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
pituitary cancer 1 | 1,972
sarcoidosis 1 | 358
tuberculosis 1 | 1,557

Tissue

Cardiovascular System 4 | 17,958
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Nervous System 4 | 18,561
Urinary Tract 4 | 18,444
Blood and immune system 3 | 17,995
Digestive Tract 3 | 18,473
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115

Target Family

Non-IDG 2 | 11,971
GPCR 1 | 406
Nuclear Receptor 1 | 48

Grant Application

5R01MH058448-10 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Regulator of G-protein signaling 20 RGS20 Tbio Non-IDG -1.25470 19.0 106
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Estrogen receptor beta ESR2 Tclin Nuclear Receptor -3.53167 3575.4 950
5-hydroxytryptamine receptor 1A HTR1A Tclin GPCR -3.67081 4839.2 234